Therapeutics: Receptor activator of NF-κB ligand (RANKL; TNFSF11); macrophage colony-stimulating factor 1 (CSF1; M-CSF)

Musculoskeletal disease

INDICATION: Osteoporosis

Cell culture and rodent studies suggest indazole-based inhibitors of RANKL signaling could help treat osteoporosis. Chemical synthesis and in vitro

Read the full 220 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE